Pharmaceuticals and vector-control programmes have greatly diminished the once-widespread disease, but sustained effort will ...
2d
According to the scientists of the National Research University "BelSU", the obtained results allow us to conclude that the ...
KLS-1 is under clinical development by Vector Vitale and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...
Charles Xie is the founder and CEO of Zilliz, focusing on building next-generation databases and search technologies for AI ...
SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell ...
New agreement enables both companies to fuel a broad and innovative pipeline of 212Pb-Radio-DARPin candidates, bringing the total number of ...
A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...
A look back at my 2024 predictions is revealing. . Each year I dust off my crystal ball and attempt to divine what lies ahead ...
The campus would include a sheriff’s station, and the infrastructure to accommodate firefighting, culinary, farm, and auto ...
A federal judge in Texas has blocked the U.S. Food and Drug Administration from enforcing a looming requirement that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback